Identification of new predictive factors for chemo-radiation against oral cancers and setting of individualized medicine based on their expressions
Project/Area Number |
21592555
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Surgical dentistry
|
Research Institution | Yamaguchi University |
Principal Investigator |
HARADA Koji 山口大学, 大学院・医学系研究科, 助教 (60253217)
|
Project Period (FY) |
2009 – 2011
|
Project Status |
Completed (Fiscal Year 2011)
|
Budget Amount *help |
¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2011: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2010: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2009: ¥2,340,000 (Direct Cost: ¥1,800,000、Indirect Cost: ¥540,000)
|
Keywords | 口腔癌 / 化学放射線療法 / 効果予測 / 耐性株 / 5-FU耐性 / 放射線耐性 |
Research Abstract |
We established anticancer drug-resistant or radiation-resistant oral cancer cell lines. The specific fluctuating genes between a 5-FU-resistant cell line and a non 5-FU-resistant cell line were identified through microarray analysis, and we identified candidate genes including GDF15. We found a trifluorothymidine by investigating the agent can suppress the candidate gene expression. These finding suggested that trifluorothymidine based chemotherapy may be one of options for recurrent cases after 5-FU based chemotherapy.
|
Report
(4 results)
Research Products
(21 results)